Novo Nordisk Shares Fall After Data From New Eli Lilly Pill
In This Article:
The stock fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s blockbuster shots.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The stock fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s blockbuster shots.